Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancement of Glucagon Counterregulation in Type 1 Diabetes by Basal Amylin Replacement

NCT03547427 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT03547427
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03547427 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancement of Glucagon Counterregulation in Type 1 Diabetes by Basal Amylin Replacement
Lead sponsor
University of Virginia
Phase
Not applicable
Overall status
Terminated
Start date
May 20, 2018
Completion date
March 11, 2019
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus